BARD1 Life Sciences Limited Price Chart
BARD1 Life Sciences Limited BD1.XA Financial and Trading Overview
| BARD1 Life Sciences Limited stock price | 1.04 AUD |
| Previous Close | 1.04 AUD |
| Open | 1.06 AUD |
| Bid | 1.03 AUD x N/A |
| Ask | 1.05 AUD x N/A |
| Day's Range | 1.04 - 1.06 AUD |
| 52 Week Range | 1.04 - 1.06 AUD |
| Volume | 14.39K AUD |
| Avg. Volume | N/A |
| Market Cap | N/A |
| Beta (5Y Monthly) | -0.644161 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 AUD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
BD1.XA Valuation Measures
| Enterprise Value | 91.42M AUD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 2.8512394 |
| Enterprise Value/Revenue | 71.939 |
| Enterprise Value/EBITDA | -15.65 |
Trading Information
BARD1 Life Sciences Limited Stock Price History
| Beta (5Y Monthly) | -0.644161 |
| 52-Week Change | N/A |
| S&P500 52-Week Change | N/A |
| 52 Week High | 1.06 AUD |
| 52 Week Low | 1.04 AUD |
| 50-Day Moving Average | N/A |
| 200-Day Moving Average | N/A |
BD1.XA Share Statistics
| Avg. Volume (3 month) | N/A |
| Avg. Daily Volume (10-Days) | N/A |
| Shares Outstanding | N/A |
| Float | 73.42M |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | N/A |
| Trailing Annual Dividend Yield | N/A |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2021 |
| Most Recent Quarter (mrq) | June 30, 2021 |
| Next Fiscal Year End | June 30, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -509.76% |
| Gross Margin | -39.30% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -19.80% |
| Return on Equity (ttm) | -62.76% |
Income Statement
| Revenue (ttm) | 1.27M AUD |
| Revenue Per Share (ttm) | 0.02 AUD |
| Quarterly Revenue Growth (yoy) | 109.80% |
| Gross Profit (ttm) | -499407 AUD |
| EBITDA | -5841444 AUD |
| Net Income Avi to Common (ttm) | -11150880 AUD |
| Diluted EPS (ttm) | -0.144 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 5M AUD |
| Total Cash Per Share (mrq) | 0.05 AUD |
| Total Debt (mrq) | 1.26M AUD |
| Total Debt/Equity (mrq) | 4.35 AUD |
| Current Ratio (mrq) | 3.871 |
| Book Value Per Share (mrq) | 0.363 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -5260377 AUD |
| Levered Free Cash Flow (ttm) | -3667164 AUD |
Profile of BARD1 Life Sciences Limited
| Country | Australia |
| State | VIC |
| City | Notting Hill |
| Address | 23 Normanby Road |
| ZIP | 3168 |
| Phone | 61 3 9548 7586 |
| Website | https://www.bard1.com |
| Industry | |
| Sector(s) | |
| Full Time Employees | 15 |
BARD1 Life Sciences Limited engages in the research, development, and commercialization of diagnostic products for the early detection of cancer to enhance patient outcomes in Australia. The company offers hTERT test used as an adjunct to urine cytology testing for bladder cancer; and EXO-NET pan-exosome capture tool for research purposes. Its cancer diagnostic pipeline includes blood tests in development for ovarian and breast cancers, and research-stage projects for prostate and other cancers. BARD1 Life Sciences Limited was incorporated in 1983 and is headquartered in Notting Hill, Australia.
Q&A For BARD1 Life Sciences Limited Stock
What is a current BD1.XA stock price?
BARD1 Life Sciences Limited BD1.XA stock price today per share is 1.04 AUD.
How to purchase BARD1 Life Sciences Limited stock?
You can buy BD1.XA shares on the CXA exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for BARD1 Life Sciences Limited?
The stock symbol or ticker of BARD1 Life Sciences Limited is BD1.XA.
How many shares does BARD1 Life Sciences Limited have in circulation?
The max supply of BARD1 Life Sciences Limited shares is 0.
What is BARD1 Life Sciences Limited Price to Earnings Ratio (PE Ratio)?
BARD1 Life Sciences Limited PE Ratio is 0.00000000 now.
What was BARD1 Life Sciences Limited earnings per share over the trailing 12 months (TTM)?
BARD1 Life Sciences Limited EPS is 0 AUD over the trailing 12 months.